CorMedix Inc.
CRMD
$8.65
$0.111.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 127.43M | 128.62M | 104.28M | 39.74M | 39.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.43M | 128.62M | 104.28M | 39.74M | 39.08M |
| Cost of Revenue | 12.01M | 11.17M | 7.57M | 1.86M | 1.55M |
| Gross Profit | 115.42M | 117.45M | 96.71M | 37.87M | 37.54M |
| SG&A Expenses | 34.25M | 29.38M | 36.64M | 15.89M | 14.17M |
| Depreciation & Amortization | 10.30M | 10.14M | 3.63M | -- | 52.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.77M | 59.29M | 52.93M | 20.19M | 18.96M |
| Operating Income | 63.66M | 69.33M | 51.35M | 19.54M | 20.13M |
| Income Before Tax | 55.65M | 56.45M | 52.58M | 20.35M | 20.64M |
| Income Tax Expenses | 17.04M | 42.43M | -55.99M | 521.50K | -- |
| Earnings from Continuing Operations | 38.60M | 14.02M | 108.56M | 19.83M | 20.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.60M | 14.02M | 108.56M | 19.83M | 20.64M |
| EBIT | 63.66M | 69.33M | 51.35M | 19.54M | 20.13M |
| EBITDA | 74.20M | 79.76M | 55.14M | 19.71M | 20.29M |
| EPS Basic | 0.49 | 0.17 | 1.43 | 0.29 | 0.32 |
| Normalized Basic EPS | 0.50 | 0.54 | 0.43 | 0.19 | 0.20 |
| EPS Diluted | 0.43 | 0.16 | 1.26 | 0.28 | 0.30 |
| Normalized Diluted EPS | 0.43 | 0.46 | 0.38 | 0.18 | 0.19 |
| Average Basic Shares Outstanding | 79.51M | 78.84M | 75.93M | 67.93M | 65.24M |
| Average Diluted Shares Outstanding | 92.99M | 93.92M | 86.21M | 71.92M | 68.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |